Says the guy that is still really excited about this and putting all their eggs in this basket to maybe get an offer for a product that might get approved.You're both idiots. GFY
One blindside from the FDA not enough to open up your eyes? Here is a second non-approval from today. Analysts had rated Biomarin as a stock to buy based on the favorable profile of their treatment.
Glad you know what the FDA will do for Acadia
https://www.barrons.com/articles/bi...rejection-hemophilia-gene-therapy-51597853794
Ummmm read this thread Chief. First things first. Yes $120k base for PC sales was talked about which I said doesn’t happen and is a fact!!
Secondly the only company you could name that paid more $135k base Biogen & that’s a lie. Lololol. Omg what a loser. Why tf are you trying to convince people of this. Biogen was paying $120k base up until the last year. With their potential expansion they’ve moved it up to $135-$140k base base on experience and success.
So this list of companies that pay more than $135....we are still waiting bud lololol.
Again. Many companies only pay $120k-$125k base for specialty.
I’m interviewing at Acadia and they are offering $135k and that’s very rare.
I bet 95% of specialty Companies don’t offer that much.
I was specialty at Abbie making $115k. I went to Teva specialty and they could only offer $120k max and I had to produce documentation of success and the last 2 years of Annual field ride evals to get $120k because they said they rarely brought people in at $120k base.
Acadia said they base salary off of experience and it’s non-negotiable and told me they’d offer $135. I have a final interview coming up soon.